Related Experiment Video
Updated: Oct 31, 2025

05:05
Author Spotlight: Integrating Eastern and Western Medicine for Treatment of Granulomatous Mastitis
Published on: May 3, 2024
1.4K
Granulomatous mastitis treatment options and our experience
Summary
Granulomatous mastitis (GM), a rare breast inflammation, often recurs due to varied treatments. Surgical excision with clear margins offers the best chance for successful outcomes, despite the availability of conservative options.
Area of Science:
- Breast Pathology
- Surgical Oncology
- Inflammatory Diseases
Background:
- Granulomatous mastitis (GM) is a rare, benign inflammatory breast condition.
- Clinical presentation includes unilateral breast mass, pain, and resistance.
- Definitive diagnosis relies on biopsy showing non-caseifying granulomas and potential microabscesses.
Purpose of the Study:
- To evaluate treatment strategies for granulomatous mastitis.
- To highlight the high recurrence rate associated with current therapies.
- To present case reports on patient treatment outcomes.
Main Methods:
- Review of diagnostic methods, emphasizing sonography and biopsy.
- Analysis of treatment options: conservative (corticosteroids) versus surgical (mastectomy).
- Discussion of surgical principles including radicality and reconstructive techniques.
Main Results:
- GM exhibits a high recurrence rate, nearing 50%, indicating suboptimal current treatments.
- Conservative treatments (e.g., oral steroids) have high recurrence risks.
- Surgical excision with negative margins is associated with lower recurrence rates.
Conclusions:
- Current treatments for GM are often suboptimal, leading to high recurrence.
- Surgical intervention with thorough excision is crucial for successful management.
- While conservative options exist, surgery remains a key treatment modality for GM.
Related Concept Videos
Tonsillitis II: Management
228
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
228
Pulmonary Tuberculosis V
285
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
285
Acute Pancreatitis II: Clinical Manifestations and Management
347
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
347
Acute Pyelonephritis II: Diagnostic Studies and Management
94
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
94
Myasthenia Gravis: Overview and Treatment
2.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.3K

